Lindbrook Capital LLC Has $123,000 Stake in Aflac Incorporated (NYSE:AFL)

Lindbrook Capital LLC boosted its holdings in shares of Aflac Incorporated (NYSE:AFL) by 39.0% in the fourth quarter, HoldingsChannel reports. The firm owned 1,489 shares of the financial services provider’s stock after acquiring an additional 418 shares during the period. Lindbrook Capital LLC’s holdings in Aflac were worth $123,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of AFL. Flagship Harbor Advisors LLC acquired a new stake in shares of Aflac in the 3rd quarter valued at $268,000. Impact Partnership Wealth LLC increased its stake in shares of Aflac by 471.4% in the 3rd quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider’s stock valued at $31,000 after buying an additional 330 shares during the period. 1900 Wealth Management LLC acquired a new stake in shares of Aflac in the 3rd quarter valued at $248,000. Dominguez Wealth Management Solutions Inc. increased its stake in shares of Aflac by 0.5% in the 3rd quarter. Dominguez Wealth Management Solutions Inc. now owns 24,969 shares of the financial services provider’s stock valued at $1,916,000 after buying an additional 132 shares during the period. Finally, Hanlon Investment Management Inc. increased its stake in shares of Aflac by 14.7% in the 3rd quarter. Hanlon Investment Management Inc. now owns 5,987 shares of the financial services provider’s stock valued at $460,000 after buying an additional 768 shares during the period. 67.44% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, SVP Albert Riggieri sold 8,000 shares of the business’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $83.34, for a total value of $666,720.00. Following the sale, the senior vice president now directly owns 32,825 shares in the company, valued at $2,735,635.50. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, SVP Albert Riggieri sold 8,000 shares of the business’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $83.34, for a total value of $666,720.00. Following the sale, the senior vice president now directly owns 32,825 shares in the company, valued at $2,735,635.50. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total value of $423,100.00. Following the completion of the sale, the director now owns 17,920 shares in the company, valued at $1,516,390.40. The disclosure for this sale can be found here. Insiders have sold a total of 46,493 shares of company stock worth $3,765,706 over the last three months. Corporate insiders own 0.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Wells Fargo & Company lowered their target price on Aflac from $83.00 to $81.00 and set an “equal weight” rating for the company in a research note on Thursday, April 11th. Raymond James lifted their price objective on Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a research note on Friday, February 2nd. Morgan Stanley lifted their price objective on Aflac from $80.00 to $84.00 and gave the stock an “equal weight” rating in a research note on Monday, April 15th. UBS Group lifted their price objective on Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 10th. Finally, The Goldman Sachs Group lifted their price objective on Aflac from $61.00 to $75.00 and gave the stock a “sell” rating in a research note on Tuesday, January 9th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Aflac presently has a consensus rating of “Hold” and a consensus target price of $82.15.

Aflac Stock Performance

AFL stock opened at $83.75 on Wednesday. The business’s 50-day moving average price is $82.43 and its two-hundred day moving average price is $81.68. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.33. The firm has a market cap of $48.19 billion, a PE ratio of 10.81, a P/E/G ratio of 2.28 and a beta of 0.91. Aflac Incorporated has a 1-year low of $64.10 and a 1-year high of $86.26.

Aflac (NYSE:AFL) last posted its earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing the consensus estimate of $1.47 by ($0.22). The business had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $4.44 billion. Aflac had a return on equity of 17.59% and a net margin of 24.92%. During the same quarter in the prior year, the firm posted $1.29 earnings per share. As a group, research analysts forecast that Aflac Incorporated will post 6.41 earnings per share for the current year.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.